Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevention of Secondary Infections by Interferon Gamma in ICU-acquired Sustained Immune-suppression: a Randomized Trial

NCT06774235 is registered in ClinicalTrials.gov with University Hospital, Limoges as lead sponsor.

NCT NCT06774235
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06774235 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevention of Secondary Infections by Interferon Gamma in ICU-acquired Sustained Immune-suppression: a Randomized Trial
Lead sponsor
University Hospital, Limoges
Phase
Phase 3
Overall status
Recruiting
Start date
July 9, 2025
Completion date
October 9, 2028
Enrollment
326 (estimated)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

sustained immunosuppression